Molecular Diagnosis and Genetic Counseling of the Manifesting Carrier of Duchenne Muscular Dystrophy

  • Eric P. Hoffman
  • James Giron
Part of the Methods in Molecular Medicine book series (MIMM, volume 43)

Abstract

The large majority of female carriers (heterozygotes) of Duchenne or Becker muscular dystrophies (DMD/BMD) show no overt clinical symptoms. Although most carriers have been reported to have heart abnormalities by imaging technologies (echocardiography), the majority of female carriers do not show overt cardiac dysfunction (1, 2, 3).

Keywords

Vortex Phenol Chloroform Adenosine Androgen 

References

  1. 1.
    Politano, L., Nigro, V., Nigro, G., Petretta, V. R., Passamano, L., Papparella, S., Di Somma, S., and Comi, L. I. (1996) Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 275, 1335–1338PubMedCrossRefGoogle Scholar
  2. 2.
    Kinoshita, H., Goto, Y., Ishikawa, M., Uemura, T., Matsumoto, K., Hayashi, Y. K., Arahata, K., and Nonaka, I. (1995) A carrier of Duchenne muscular dystrophy with dilated cardiomyopathy but no skeletal muscle symptom. Brain Dev. 17, 202–205.PubMedCrossRefGoogle Scholar
  3. 3.
    Mirabella, M., Servidei, S., Manfredi, G., Ricci, E., Frustaci, A., Bertini, E., Rana, M., and Tonali, P. (1993) Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology 43, 2342–2345.PubMedGoogle Scholar
  4. 4.
    Hoffman et al. (1992)Google Scholar
  5. 5.
    Bushby, K. M., Goodship, J. A., Nicholson, L. V., Johnson, M. A., Haggerty, I. D., and Gardner-Medwin, D. (1993) Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy. Neuromusc. Disord. 3, 57–64.PubMedCrossRefGoogle Scholar
  6. 6.
    Azofeifa, J., Voit, T., Hubner, C., Cremer, M. (1995) X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes. Hum. Genet. 96, 167–176.PubMedCrossRefGoogle Scholar
  7. 7.
    Matthews, P. M., Benjamin, D., VanBakel, I., Squier, M.V., Nicholson, L. V., Sewry, C., et al. (1995) Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers. Neuromusc. Disord. 5 209–220.PubMedCrossRefGoogle Scholar
  8. 8.
    Bonilla, E., Younger, D. S., Chang, H. W., Tantravahi, U., Miranda, A. F., Medori, R., et al. (1990) Partial dystrophin deficiency in monozygous twin carriers of the Duchenne gene discordant for clinical myopathy. Neurology 40, 1267–1270.PubMedGoogle Scholar
  9. 9.
    Sumita, D. R., Vainzof, M., Campiotto, S., Cerqueira, A. M., Canovas, M., Otto, P.A., Passos-Bueno, M.R., and Zatz, M. (1998) Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/ Becker female carriers. Am. J. Med. Genet. 80, 356–361.PubMedCrossRefGoogle Scholar
  10. 10.
    Hoffman, E. P., Pegoraro, E., Scacheri, P., Burns, R. G., Taber, J. W., Weiss, L., Spiro, A., and Blattner, P. (1996) Genetic counseling of isolated carriers of Duchenne muscular dystrophy. Am. J. Med. Genet. 63, 573–580.PubMedCrossRefGoogle Scholar
  11. 11.
    Pegoraro, E., Schimke, R. N., Garcia, C., Stern, H., Cadaldini, M., Angelini, C., et al. (1995) Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin competent myonuclei. Neurology 45, 677–690.PubMedGoogle Scholar
  12. 12.
    Pegoraro, E., Schimke, R. N., Arahata, K., Hayashi, Y., Stern, H., Marks, H., et al. (1994) Dystrophinopathy in females: paternal inheritance and genetic counseling. Am. J. Hum. Genet. 54, 989–1003.PubMedGoogle Scholar
  13. 13.
    Pegoraro, E., Whitaker, J., Mowery-Rushton, P., Surti, U., Lanasa, M., and Hoffman, E. P. (1997) Familial skewed X-inactivation: a molecular trait associated with high spontaneous abortion rate maps to Xq28. Am. J. Hum. Genet. 61, 160–170.PubMedCrossRefGoogle Scholar
  14. 14.
    Hoffman, E. P., Brown, R. H., and Kunkel, L. M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919–928.PubMedCrossRefGoogle Scholar
  15. 15.
    Koenig, M., and Kunkel, L. M. (1990) Detailed analysis of the repeat domain of dystrophin reveals 4 potential hinge regions that may confer flexibility. J. Biol. Chem. 265, 4560–4566.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2001

Authors and Affiliations

  • Eric P. Hoffman
    • 1
  • James Giron
    • 1
  1. 1.Department of Molecular GeneticsChildren′s Research InstituteWashington, DCUSA

Personalised recommendations